Onisko B L, Schnoes H K, DeLuca H F
J Biol Chem. 1979 May 10;254(9):3493-6.
25-Azavitamin D3 inhibited both the bone calcium mobilization and intestinal calcium transport responses of rats to vitamin D3 but not to 25-hydroxyvitamin D3. Although 25-azavitamin D3 had no effect on the response of bone to 1alpha,25-dihydroxyvitamin D3, it did diminish the response of the intestine to that metabolite. 25-Azavitamin D3 increased liver vitamin D content and reduced the concentration of 25-hydroxyvitamin D3 required to inhibit the metabolism of vitamin D3 (75 and 200 microgram) were similar to the doses of 25-azavitamin D3 required to inhibit the action of vitamin D3 in vivo (50 and 150 microgram). 25-Azavitamin D3 is thus a vitamin D antagonist, acting for the most part via inhibition of the liver 25-hydroxylation of vitamin D3.
25-氮杂维生素D3抑制大鼠对维生素D3的骨钙动员和肠道钙转运反应,但不抑制对25-羟基维生素D3的反应。尽管25-氮杂维生素D3对骨对1α,25-二羟基维生素D3的反应没有影响,但它确实减弱了肠道对该代谢产物的反应。25-氮杂维生素D3增加肝脏维生素D含量,并降低抑制维生素D3代谢所需的25-羟基维生素D3浓度(75和200微克),这与体内抑制维生素D3作用所需的25-氮杂维生素D3剂量(50和150微克)相似。因此,25-氮杂维生素D3是一种维生素D拮抗剂,主要通过抑制肝脏对维生素D3的25-羟化作用发挥作用。